Eyedea Medical

Eyedea Medical is a private, pre-revenue medical device company founded in 2018 and headquartered in Baltimore, Maryland, with operations noted in San Diego. The company is targeting the significant unmet need in corneal blindness by developing a series of devices to streamline eye banking and corneal surgical procedures. Its strategy centers on creating affordable, high-quality technologies to optimize treatment, reduce healthcare costs, and expand global access to vision-restoring transplants. As an early-stage venture, Eyedea is building its platform and partnerships to address a market of over 25 million patients affected by needless corneal blindness.

A medical device platform focused on developing instruments and technologies to improve the efficiency, quality, and accessibility of corneal transplantation procedures and eye bank operations.

The competitive landscape includes established ophthalmic surgical device companies (e.g., Alcon, Bausch + Lomb) that offer instrumentation for corneal surgery, as well as other startups innovating in corneal tissue preparation, storage, and surgical techniques. Eyedea must differentiate by offering integrated solutions that specifically target workflow inefficiencies for both eye banks and surgeons at an accessible price point.